Fu, Cong
Saddawi-Konefka, Robert https://orcid.org/0000-0002-9936-1695
Chinai, Jordan M.
Kim, Sarah Y.
Kammula, Ashwin V. https://orcid.org/0000-0001-5284-721X
Perera, Jonathan J. https://orcid.org/0000-0003-3224-6075
Jiang, Aiping
Tiwari, Payal
Kistler, Erin N.
Tang, Shiqi
Luna, Sarah M. https://orcid.org/0009-0002-7211-5539
Colvin, Kayla J.
Dubrot, Juan https://orcid.org/0000-0002-8093-2208
Anderson, Seth https://orcid.org/0000-0003-2419-0585
Fetterman, Rachel A.
Chuong, Cun Lan
Lane-Reticker, Sarah K.
Cheruiyot, Collins K.
Muscato, Audrey J. https://orcid.org/0000-0003-2009-6313
Alipour, Zahra
Adkins, Douglas R.
Griffin, Gabriel K. https://orcid.org/0000-0002-4042-6757
Bernstein, Bradley E.
Egloff, Ann Marie
Yates, Kathleen B. https://orcid.org/0000-0002-7383-5573
Chernock, Rebecca D.
Gutkind, J. Silvio
Uppaluri, Ravindra https://orcid.org/0000-0001-5988-6828
Manguso, Robert T. https://orcid.org/0000-0003-1336-413X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (U01DE029188)
Article History
Received: 7 December 2024
Accepted: 25 August 2025
First Online: 29 September 2025
Competing interests
: R.T.M. receives research funding from Calico Life Sciences, LLC. R.T.M. has received speaking or consulting fees from Bristol Myers Squibb, Gilead Sciences, Kumquat Biosciences, Immunai Therapeutics, and BioNTech. R.U. reports grants and personal fees from Merck, personal fees from Regeneron, and Daichi-Sankyo. The MOC models developed by R.U. have been filed with the Washington University Office of Technology Management and are licensed for distribution by Kerafast. The remaining authors declare no competing interests.